Coronavirus: Commission approves contract with BioNTech-Pfizer alliance to ensure access to a potential vaccine

(Credit: Unsplash)

This article is brought to you in association with the European Commission.


Today, the European Commission approved a fourth contract with pharmaceutical companies BioNTech and Pfizer, which provides for the initial purchase of 200 million doses on behalf of all EU Member States, plus an option to request up to a further 100 million doses, to be supplied once a vaccine has proven to be safe and effective against COVID-19. Member States can decide to donate the vaccine to lower and middle-income countries or to re-direct it to other European countries.

Today’s contract with the BioNTech-Pfizer alliance builds upon the broad portfolio of vaccines to be produced in Europe, including the already signed a contracts with AstraZeneca, Sanofi-GSK and Janssen Pharmaceutica NV, and the concluded successful exploratory talks with CureVac and Moderna. This diversified vaccines portfolio will ensure Europe is well prepared for vaccination, once the vaccines have been proven to be safe and effective.

President of the European Commission, Ursula von der Leyen, said:  “In the wake of Monday’s promising announcement by BioNTech and Pfizer on the prospects for their vaccine, I’m very happy to announce today’s agreement with the European company BioNTech and Pfizer to purchase 300 million doses of the vaccine. With this fourth contract we are now consolidating an extremely solid vaccine candidate portfolio, most of them in advanced trials phase. Once authorised, they will be quickly deployed and bring us closer to a sustainable solution of the pandemic.

Stella Kyriakides, Commissioner for Health and Food Safety, said: “A safe and effective vaccine is the only lasting exit strategy from the pandemic, and is at the centre of our European Vaccine Strategy. Today’s agreement follows the encouraging first indications from the clinical trial results and is further evidence of our commitment to putting more Europe in the area of health. It is a very telling example of what the EU can achieve when working together, as a Union, and a case in point of what a future European Health Union will be able to deliver.”

BioNTech is a German company working with US-based Pfizer to develop a new vaccine based on messenger RNA (mRNA). mRNA plays a fundamental role in  biology, transferring instructions from DNA to cells’ protein making machinery. In an mRNA vaccine, these instructions make harmless fragments of the virus which the human body uses to build an immune response to prevent or fight disease.

The Commission has taken a decision to support this vaccine based on a sound scientific assessment, the technology used, the companies’ experience in vaccine development and their production capacity to supply the whole of the EU.

Background

The European Commission presented on 17 June a European strategy to accelerate the development, manufacturing and deployment of effective and safe vaccines against COVID-19. In return for the right to buy a specified number of vaccine doses in a given timeframe, the Commission finances part of the upfront costs faced by vaccines producers in the form of Advance Purchase Agreements. Funding provided is considered as a down-payment on the vaccines that will actually be purchased by Member States.

Since the high cost and high failure rate make investing in a COVID-19 vaccine a high-risk decision for vaccine developers, these agreements will therefore allow investments to be made that otherwise might not happen.

Once vaccines have been proven to be safe and effective and have been granted market authorisation by the European Medicines Agency, they need to be quickly distributed and deployed across Europe. On 15 October, the Commission set out the key steps that Member States need to take to be fully prepared, which includes the development of national vaccination strategies. The Commission is putting in place a common reporting framework and a platform to monitor the effectiveness of national vaccine strategies.

The European Commission is also committed to ensuring that everyone who needs a vaccine gets it, anywhere in the world and not only at home. No one will be safe until everyone is safe. This is why it has raised almost €16 billion since 4 May 2020 under the Coronavirus Global Response, the global action for universal access to tests, treatments and vaccines against coronavirus and for the global recovery and has confirmed its interest to participate in the COVAX Facility for equitable access to affordable COVID-19 vaccines everywhere. As part of a Team Europe effort, the Commission announced is contributing with €400 million in guarantees to support COVAX and its objectives in the context of the Coronavirus Global Response.

the sting Milestone

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

Youth and Decent Work: A Review of Today’s Facts, Challenges and Possible Solutions

Britain in and out of the EU

Agreement on EU instrument supporting border management and common visa policy

“Two Pack” approved: Is democracy chased away from Brussels?

9 climate tipping points pushing Earth to the point of no return

Altruism can be good for business, as these companies show

Parliament mobilised to channel EU funds to those affected by Coronavirus pandemic

More answers from Facebook ahead of Parliament hearing today

Close to final agreement on the EU Banking Union

EFSF/ESM boss tells half truths about Troika’s doings

UN highlights profound implication of population trends on sustainable development

Australia urged to evacuate offshore detainees amid widespread, acute mental distress

3 ways blockchain can revolutionize global supply chains

Keep Africa’s guns ‘from firing in the first place’, UN political chief urges

Norway initiates WTO dispute complaint against US steel, aluminium duties

Refugee crisis update: Commission is struggling alone with little help from EU or G7 leaders

The representatives of the regions and the cities know better what the EU needs on migration, trade, poverty and taxation

UN rights experts ‘gravely’ concerned at spike in civilian casualties in north-west Myanmar following internet shutdown

Innovations for Content Professionals at the DCX exhibition 2018 in Berlin, in association with The European Sting

EU migrant crisis: Germany, France and UK to show the way. Will the rest of the EU follow?

One billion people have preventable eye conditions, increasingly linked to lifestyle choices: UN health agency

‘New tech’ business model threatens decent work conditions, warns UN

Defence: European Commission paves the way for first joint industrial projects under EU budget

7 key challenges for the future of ASEAN – and how to solve them

Localized microfactories – the new face of globalized manufacturing

Eurozone’s credibility rock solid

Manufacturers Get Smarter for Industry 4.0

Tackling obesity would boost economic and social well-being

The Ukrainian crisis to destabilize Europe and the world for a long time

Is a 3-day split week the way to get people back to work?

The metamorphosis of the categorical imperative in medical students

Member States’ compliance with EU law in 2019: more work needed

The Future of Balkans: Embracing Education

It’s time for global businesses to accept local responsibility

This is how travel hotspots are fighting back against overtourism

Strong EU trade enforcement rules enter into force

Not enough resettlement solutions for refugees worldwide, says UN

Mankind’s first tool to fight malaria also kills

Connect 4 Impact – a virtual journey around the globe WSA Global Congress 2021 – March 22-24

What if nature became a legal person?

COVID-19: MEPs free up over €3 billion to support EU healthcare sector

Black historical figures who shook the world, from a warrior queen to a Mexican president

High-flyers: China is on top of the world for skyscraper construction

Services are the hidden side of the US-China trade war

Antimicrobial resistance: how can an intersectoral approach between society and healthcare professionals be developed and applied?

How digital entrepreneurs will help shape the world after the COVID-19 pandemic

Protecting refugees in Europe: UNHCR calls for a ‘year of change’

The use of mobile technologies in Radiation Oncology: helping medical care

Climate change helped destroy these four ancient civilisations

We need to talk: UN gears up for 75th anniversary with Global Conversations

Climate change will be sudden and cataclysmic. We need to act fast

Companies that put employees first perform better

How Japan and Singapore are reinventing old age

EU Commission says falling labour remuneration leads to deflation and damages growth prospects

President von der Leyen’s State of the Union Address: charting the course out of the coronavirus crisis and into the future

How climate change exacerbates the refugee crisis – and what can be done about it

Around 52 million in Near East, North Africa, suffering chronic undernourishment, new UN food agency report reveals

A climate scientist explains what the melting Arctic means for the world

UN programme to help spare millions from child marriage, extended to 2023

How global tech companies can champion ethical AI

More Stings?

Advertising

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s